YENRYA
LIVE

Serial Number

79213754

Owner

NOVARTIS AG

Filing Date

Jun 26, 2017

Add to watchlist:

No watchlists yet
View on USPTO

YENRYA Trademark

Serial Number: 79213754 • Registration: 5377474

YENRYA is a trademark filed by NOVARTIS AG on June 26, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

June 26, 2017

Registration Date

January 16, 2018

Published for Opposition

October 31, 2017

Cancellation Date

January 6, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

DEATH OF INTERNATIONAL REGISTRATION
Aug 3, 2024 DETH
CANCELLED SECTION 71
Aug 2, 2024 C71T
NOTIFICATION PROCESSED BY IB
Mar 16, 2018 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Feb 26, 2018 FICS
FINAL DISPOSITION PROCESSED
Feb 26, 2018 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Feb 15, 2018 GPAR
REGISTERED-PRINCIPAL REGISTER
Jan 16, 2018 R.PR
PUBLISHED FOR OPPOSITION
Oct 31, 2017 PUBO
NOTICE OF PUBLICATION
Oct 11, 2017 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 15, 2017 CNSA
ASSIGNED TO EXAMINER
Sep 14, 2017 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 11, 2017 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 7, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 4, 2017 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Aug 3, 2017 SDRC